The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

paramlink2: Parametric Linkage Analysis

Parametric linkage analysis of monogenic traits in medical pedigrees. Features include singlepoint analysis, multipoint analysis via 'MERLIN' (Abecasis et al. (2002) <doi:10.1038/ng786>), visualisation of log of the odds (LOD) scores and summaries of linkage peaks. Disease models may be specified to accommodate phenocopies, reduced penetrance and liability classes. 'paramlink2' is part of the 'pedsuite' package ecosystem, presented in 'Pedigree Analysis in R' (Vigeland, 2021, ISBN:9780128244302).

Version: 1.0.6
Depends: R (≥ 4.1), pedtools
Imports: pedprobr
Suggests: spelling, testthat
Published: 2024-09-07
DOI: 10.32614/CRAN.package.paramlink2
Author: Magnus Dehli Vigeland ORCID iD [aut, cre]
Maintainer: Magnus Dehli Vigeland <m.d.vigeland at medisin.uio.no>
BugReports: https://github.com/magnusdv/paramlink2/issues
License: GPL-3
URL: https://github.com/magnusdv/paramlink2
NeedsCompilation: no
SystemRequirements: MERLIN (https://csg.sph.umich.edu/abecasis/merlin/) for multipoint linkage analysis.
Language: en-GB
Materials: README NEWS
CRAN checks: paramlink2 results

Documentation:

Reference manual: paramlink2.pdf

Downloads:

Package source: paramlink2_1.0.6.tar.gz
Windows binaries: r-devel: paramlink2_1.0.6.zip, r-release: paramlink2_1.0.6.zip, r-oldrel: paramlink2_1.0.6.zip
macOS binaries: r-release (arm64): paramlink2_1.0.6.tgz, r-oldrel (arm64): paramlink2_1.0.6.tgz, r-release (x86_64): paramlink2_1.0.6.tgz, r-oldrel (x86_64): paramlink2_1.0.6.tgz
Old sources: paramlink2 archive

Reverse dependencies:

Reverse imports: pedsuite

Linking:

Please use the canonical form https://CRAN.R-project.org/package=paramlink2 to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.